MURFREESBORO, Tenn. / Nov 08, 2024 / Business Wire / National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2024 totaled $340,198,000 compared to $288,485,000 for the quarter ended September 30, 2023, an increase of 17.9%. The increase in net operating revenues for the third quarter of 2024 compared to the same period last year was primarily related to the August 1, 2024 acquisition of White Oak Manor (“White Oak”). The White Oak operations consist of 21 healthcare operations, which includes 15 skilled nursing facilities, two assisted living facilities, and four independent living facilities.
For the quarter ended September 30, 2024, the reported GAAP net income attributable to NHC was $42,789,000 compared to $10,388,000 for the same period in 2023. Excluding the unrealized gains or losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2024 was $19,910,000 compared to $13,250,000 for the same period in 2023, an increase of 50.3% (*). The GAAP diluted earnings per share were $2.73 for the quarter ended September 30, 2024 compared to $0.68 for the quarter ended September 30, 2023. Adjusted diluted earnings per share were $1.27 and $0.86 for the quarters ended September 30, 2024 and 2023, respectively (*).
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About NHC
NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,349 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.
| Consolidated Statements of Operations | |||||||||||||||
| (in thousands, except share and per share amounts) | |||||||||||||||
Three Months Ended |
| Nine Months Ended | |||||||||||||
September 30 |
| September 30 | |||||||||||||
| 2024 |
|
|
| 2023 |
|
|
| 2024 |
|
|
| 2023 |
| |
(unaudited) |
| (unaudited) | |||||||||||||
| Revenues and grant income: | |||||||||||||||
| Net patient revenues | $ | 328,674 |
| $ | 277,005 |
| $ | 894,415 |
| $ | 804,617 |
| |||
| Other revenues |
| 11,524 |
|
| 11,480 |
|
| 34,172 |
|
| 36,013 |
| |||
| Government stimulus income |
| - |
|
| - |
|
| 9,445 |
|
| - |
| |||
| Net operating revenues and grant income |
| 340,198 |
|
| 288,485 |
|
| 938,032 |
|
| 840,630 |
| |||
| Costs and expenses: | |||||||||||||||
| Salaries, wages and benefits |
| 213,395 |
|
| 182,664 |
|
| 576,609 |
|
| 525,782 |
| |||
| Other operating |
| 82,509 |
|
| 72,490 |
|
| 238,092 |
|
| 217,213 |
| |||
| Facility rent |
| 10,886 |
|
| 10,094 |
|
| 31,804 |
|
| 30,087 |
| |||
| Depreciation and amortization |
| 10,619 |
|
| 10,135 |
|
| 30,543 |
|
| 30,266 |
| |||
| Interest |
| 1,742 |
|
| 77 |
|
| 1,788 |
|
| 268 |
| |||
| Total costs and expenses |
| 319,151 |
|
| 275,460 |
|
| 878,836 |
|
| 803,616 |
| |||
| Income from operations |
| 21,047 |
|
| 13,025 |
|
| 59,196 |
|
| 37,014 |
| |||
| Non-operating income |
| 4,224 |
|
| 4,097 |
|
| 14,865 |
|
| 12,116 |
| |||
| Unrealized gains/(losses) on marketable equity securities |
| 32,767 |
|
| (3,093 | ) |
| 56,290 |
|
| 2,943 |
| |||
| Income before income taxes |
| 58,038 |
|
| 14,029 |
|
| 130,351 |
|
| 52,073 |
| |||
| Income tax provision |
| (15,338 | ) |
| (3,908 | ) |
| (34,294 | ) |
| (14,750 | ) | |||
| Net income |
| 42,700 |
|
| 10,121 |
|
| 96,057 |
|
| 37,323 |
| |||
| Net (income)/loss attributable to noncontrolling interest |
| 89 |
|
| 267 |
|
| (211 | ) |
| 1,069 |
| |||
| Net income attributable to National HealthCare Corporation | $ | 42,789 |
| $ | 10,388 |
| $ | 95,846 |
| $ | 38,392 |
| |||
| Net income per common share | |||||||||||||||
| Basic | $ | 2.78 |
| $ | 0.68 |
| $ | 6.23 |
| $ | 2.51 |
| |||
| Diluted | $ | 2.73 |
| $ | 0.68 |
| $ | 6.15 |
| $ | 2.50 |
| |||
| Weighted average common shares outstanding | |||||||||||||||
| Basic |
| 15,411,680 |
|
| 15,299,913 |
|
| 15,384,758 |
|
| 15,311,453 |
| |||
| Diluted |
| 15,667,321 |
|
| 15,324,511 |
|
| 15,576,294 |
|
| 15,334,269 |
| |||
| Dividends declared per common share | $ | 0.61 |
| $ | 0.59 |
| $ | 1.81 |
| $ | 1.75 |
| |||
| Balance Sheet Data | September 30 |
| December 31 | ||||||||||||
| (in thousands) |
| 2024 |
|
|
| 2023 |
| ||||||||
(unaudited) |
|
| |||||||||||||
| Cash, cash equivalents and marketable securities | $ | 249,561 |
| $ | 223,620 |
| |||||||||
| Restricted cash, cash equivalents and marketable securities |
| 177,179 |
|
| 167,971 |
| |||||||||
| Current assets |
| 445,726 |
|
| 406,235 |
| |||||||||
| Property and equipment, net |
| 686,425 |
|
| 493,329 |
| |||||||||
| Total assets |
| 1,562,707 |
|
| 1,310,796 |
| |||||||||
| Current liabilities, excluding long-term debt due within one year |
| 240,446 |
|
| 214,476 |
| |||||||||
| Current and long-term debt |
| 147,000 |
|
| - |
| |||||||||
| NHC stockholders' equity |
| 983,468 |
|
| 908,752 |
| |||||||||
| Selected Operating Statistics | ||||||||||||||||
Three Months Ended |
| Nine Months Ended | ||||||||||||||
September 30 |
| September 30 | ||||||||||||||
| 2024 |
|
|
| 2023 |
|
|
| 2024 |
|
|
| 2023 |
| ||
(unaudited) |
| (unaudited) | ||||||||||||||
| Skilled Nursing Per Diems: | ||||||||||||||||
| Medicare | $ | 578.12 |
| $ | 551.82 |
| $ | 579.24 |
| $ | 552.21 |
| ||||
| Managed Care |
| 459.94 |
|
| 489.18 |
|
| 459.64 |
|
| 460.20 |
| ||||
| Medicaid |
| 290.00 |
|
| 256.46 |
|
| 274.44 |
|
| 248.99 |
| ||||
| Private Pay and Other |
| 323.36 |
|
| 283.49 |
|
| 315.09 |
|
| 279.12 |
| ||||
| Average Skilled Nursing Per Diem | $ | 350.85 |
| $ | 325.34 |
| (1) | $ | 344.76 |
| (1) | $ | 320.09 |
| (1) | |
| Skilled Nursing Patient Days: | ||||||||||||||||
| Medicare |
| 79,957 |
|
| 75,215 |
|
| 235,715 |
|
| 239,228 |
| ||||
| Managed Care |
| 70,635 |
|
| 61,979 |
|
| 199,023 |
|
| 179,992 |
| ||||
| Medicaid |
| 344,940 |
|
| 290,887 |
|
| 906,265 |
|
| 852,074 |
| ||||
| Private Pay and Other |
| 177,846 |
|
| 170,857 |
|
| 485,523 |
|
| 492,279 |
| ||||
| Total Skilled Nursing Patient Days |
| 673,378 |
|
| 598,938 |
| (1) |
| 1,826,526 |
| (1) |
| 1,763,573 |
| (1) | |
| (1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the first quarter of 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $259.56 and 20,267 patient days. For the three months ended September 30, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $244.20 and 32,141 patient days. For the nine months ended September 30, 2023, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $248.51 and 95,030 patient days. | ||||||||||||||||
| The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | ||||||||||||||||
Three Months Ended |
| Nine Months Ended | ||||||||||||||
September 30 |
| September 30 | ||||||||||||||
| 2024 |
|
|
| 2023 |
|
|
| 2024 |
|
|
| 2023 |
| ||
(unaudited) |
| (unaudited) | ||||||||||||||
| Net income attributable to National Healthcare Corporation | $ | 42,789 |
| $ | 10,388 |
| $ | 95,846 |
| $ | 38,392 |
| ||||
| Non-GAAP adjustments | ||||||||||||||||
| Unrealized (gains)/losses on marketable equity securities |
| (32,767 | ) |
| 3,093 |
|
| (56,290 | ) |
| (2,943 | ) | ||||
| Operating results for newly opened operations not at full capacity (2) |
| 120 |
|
| 66 |
|
| 140 |
|
| 1,616 |
| ||||
| Stock-based compensation expense |
| 1,093 |
|
| 708 |
|
| 3,062 |
|
| 2,119 |
| ||||
| Gain on sale of unconsolidated company |
| - |
|
| - |
|
| (1,024 | ) |
| - |
| ||||
| Acquisition-related expenses (3) |
| 637 |
|
| - |
|
| 2,831 |
|
| - |
| ||||
| Employee retention credit |
| - |
|
| - |
|
| (9,445 | ) |
| - |
| ||||
| Income tax provision on non-GAAP adjustments |
| 8,038 |
|
| (1,005 | ) |
| 15,789 |
|
| (206 | ) | ||||
| Non-GAAP Net income | $ | 19,910 |
| $ | 13,250 |
| $ | 50,909 |
| $ | 38,978 |
| ||||
| GAAP diluted earnings per share | $ | 2.73 |
| $ | 0.68 |
| $ | 6.15 |
| $ | 2.51 |
| ||||
| Non-GAAP adjustments | ||||||||||||||||
| Unrealized (gains)/losses on marketable equity securities |
| (1.55 | ) |
| 0.15 |
|
| (2.67 | ) |
| (0.14 | ) | ||||
| Operating results for newly opened operations not at full capacity (2) |
| 0.01 |
|
| - |
|
| 0.01 |
|
| 0.07 |
| ||||
| Stock-based compensation expense |
| 0.05 |
|
| 0.03 |
|
| 0.15 |
|
| 0.10 |
| ||||
| Gain on sale of unconsolidated company |
| - |
|
| - |
|
| (0.05 | ) |
| - |
| ||||
| Acquisition-related expenses (3) |
| 0.03 |
|
| - |
|
| 0.13 |
|
| - |
| ||||
| Employee retention credit |
| - |
|
| - |
|
| (0.45 | ) |
| - |
| ||||
| Non-GAAP diluted earnings per share | $ | 1.27 |
| $ | 0.86 |
| $ | 3.27 |
| $ | 2.54 |
| ||||
| (2) The operating results for newly opened facilities or agencies not at full capacity include healthcare operations that are still considered in the start-up phase, which are two hospice agencies for the three and nine months ended September 30, 3024. For the three and nine months ended September 30, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies. | ||||||||||||||||
| (3) Represents expenses incurred to acquire the White Oak operations that are not capitalizable. | ||||||||||||||||
| Last Trade: | US$111.29 |
| Daily Change: | 0.34 0.31 |
| Daily Volume: | 9,011 |
| Market Cap: | US$1.720B |
August 09, 2024 February 16, 2024 November 03, 2023 August 04, 2023 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
